Amitabh Chandra

The Big Problem With High Health Care Deductibles

The Big Problem With High Health Care Deductibles

February 5, 2016

By Margot Sanger-Katz - The New York Times

Amitabh Chandra, an economist at Harvard, and one of the researchers, said he was convinced the study would prove the value of deductibles, at least for well-off and well-educated workers. He was wrong. Over all, the workers did spend less on health care. Spending fell by about 12 percent, a remarkable decline. But the way workers achieved those savings gave the researchers pause.

The myth of 'consumer-driven healthcare' comes to life again

The myth of 'consumer-driven healthcare' comes to life again

December 14, 2015

By Michael Hiltzik - LA Times

"Simply calling a patient a consumer doesn’t make buying healthcare like buying cars," healthcare economist Amitabh Chandra of Harvard acknowledged recently in Forbes. "In healthcare, the consumer (i.e. the patient) is sick, tired, confused, distracted—they want their doctor or their insurer to help them manage the health-care that they need."

A Nuanced Take On Healthcare Consumerism

A Nuanced Take On Healthcare Consumerism

December 14, 2015

By David Shaywitz - Forbes

Following up on Gaynor’s second point, questioning our demonstrated ability to be good healthcare consumers, I asked Amitabh Chandra, a health economist at Harvard [...] to discuss his research on this question.

New Study Outlines Impacts of Higher Health Insurance Deductibles

New Study Outlines Impacts of Higher Health Insurance Deductibles

October 22, 2015

By Doug Gavel - Harvard Kennedy School

Higher health care insurance deductibles are changing consumer behavior, but in ways that might lead to worse long-term health outcomes. That is one finding in a new study, co-authored by Professor Amitabh Chandra, examining the ways in which health care consumers are responding to a new trend in the insurance industry—higher deductible plans designed to serve as a check on the increasing demand for services.

Baker: Lowell General Hospital an industry model

Baker: Lowell General Hospital an industry model

October 6, 2015

By Andy Metzger - Lowell Sun

While extolling the importance of competition, Amitabh Chandra, professor of social policy and director of health-policy research at Harvard's Kennedy School of Government, included price transparency with management of population health, and wellness programs as ideas that should elicit skepticism.

Baker Outlines His Take on Healthcare Costs

Baker Outlines His Take on Healthcare Costs

October 5, 2015

By Andy Metzger - State House News Service

While extolling the importance of competition, Harvard Kennedy School professor Amitabh Chandra included price transparency with management of population health, and wellness programs as ideas that should elicit skepticism. "We have to be extremely skeptical of all the something-for-nothing remedies," Chandra told the Health Policy Commission Monday... 

State Capitol Briefs - Lunch Edition

State Capitol Briefs - Lunch Edition

October 5, 2015

State House News Service

Amitabh Chandra, a health policy expert and economist, told the commission that innovation in the sector will be spurred by new patients receiving coverage through the Affordable Care Act, and that is likely to drive up costs. Chandra also warned against embracing "snake oil" cures for cost growth, which he identified as transparency tools and spending on wellness, which he said is beneficial but not necessarily a cost-saver.

Baker tips cap to Lowell General Hospital at health-costs hearing

Baker tips cap to Lowell General Hospital at health-costs hearing

October 5, 2015

By State House News Service - Lowell Sun

Amitabh Chandra, a health-policy expert and economist, told the commission that innovation in the sector will be spurred by new patients receiving coverage through the Affordable Care Act, and that is likely to drive up costs. Chandra also warned against embracing "snake oil" cures for cost growth, which he identified as transparency tools and spending on wellness, which he said is beneficial but not necessarily a cost-saver. "There's really no substitute to paying less or doing less," Chandra said.

Greedy Pharma CEO Cancels 5,000% Price Hike -- But He Didn't Fix The Real Problem

Greedy Pharma CEO Cancels 5,000% Price Hike -- But He Didn't Fix The Real Problem

September 22, 2015

By Dan Diamond - Forbes

Harvard’s Amitabh Chandra tells the New York Times that Clinton’s proposal to force pharma companies to reinvest profits into R&D is “astonishingly naïve”; there’s no evidence that pharma firms aren’t doing enough research, and pushing them to spend more upfront would seem to do little to lower the actual costs of drugs. 

Why Some Policy Experts Question Clinton’s Plan to Contain Drug Costs

Why Some Policy Experts Question Clinton’s Plan to Contain Drug Costs

September 22, 2015

By Margot Sanger-Katz - The Upshot - The New York Times

“This is an astonishingly naïve approach,” said Amitabh Chandra, a professor of public policy at Harvard University, in an email. He argues that the plan could encourage wasteful research spending without necessarily doing much about the prices charged for medications.